Skip to main content
. 2020 Jun 19;10(6):932. doi: 10.3390/biom10060932

Figure 5.

Figure 5

Ingenuity Pathways Analysis (IPA) showing upstream regulators for NF-κB and ERK1/2 for VA vs. Ctr treatment group predicted to be inhibited. The predicted inhibition of these putative upstream regulators largely agrees with the observed downregulation of numerous chemokines and cytokines. (a) Upstream regulator network for an inhibited NF-κB complex. (b) Upstream regulator network for an inhibited ERK1/2 complex.